| HOME >> BIOLOGY >> TECHNOLOGY |
$ 0.73
$ (0.30)
$ 0.43$ 0.61
$ (0.04)
$ 0.57Diluted
$ 0.72
$ (0.30)
$ 0.42$ 0.61
$ (0.05)
$ 0.56Weighted average shares outstanding:Basic
46,11746,11747,82747,827Diluted
46,94446,94448,45548,455Gen-Probe IncorporatedConsolidated Statements of Income – Non-GAAP Reconciliations(In thousands, except per share data)
(Unaudited)Twelve Months EndedTwelve Months EndedDecember 31, 2011December 31, 2010Non-GAAPAdjustmentsGAAPNon-GAAPAdjustmentsGAAPRevenues:Product sales
$562,588
$ —
$562,588$522,709
$ —
$522,709Collaborative research revenue
7,682
—
7,68214,518
—
14,518Royalty and license revenue
5,964
—
5,9646,100
—
6,100Total revenues
576,234
—
576,234543,327
—
543,327Operating expenses:Cost of product sales (excluding acquisition-related intangible amortization)
173,216
429
173,645168,860
362
169,222Acquisition-related intangible amortization
—
11,061
11,061—
8,847
8,847Research and development
112,633
109
112,742111,103
—
111,103Marketing and sales
68,359
37
68,39659,492
—
59,492General and administrative
66,170
5,224
71,39454,491
2,327
56,818Goodwill and asset impairment charges
—
12,746
12,746—
—
—Total operating expenses
420,378
29,606
449,984393,946
11,536
405,482Income from operations
155,856
(29,606)
126,250149,381
(11,536)
137,845Other income (
'/>"/>
| SOURCE Gen-Probe Incorporated Copyright©2010 PR Newswire. All rights reserved |